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Abstract
Aim To determine if hospital admission rates for diabetes complications (acute complications, chronic complications,
no complications and hypoglycaemia) were associated with primary care diabetes management.
Methods We performed an observational study in the population in England during the period 2004–2009 (54 741 278
people registered with 8140 general practices). We used multivariable negative binomial regression to model the
associations between indirectly standardized hospital admission rates for complications and primary healthcare quality,
supply and access indicators, diabetes prevalence and population factors.
Results In multivariate regression models, increasing deprivation (incidence rate ratio: 1.0154; P < 0.001, 95% CI
1.0141–1.0166) and diabetes prevalence (incidence rate ratio: 1.0956; P < 0.001, 95% CI 1.0677–1.1241) were risk
factors for admission, while most healthcare covariates, i.e. a larger practice population (incidence rate ratio 0.9999,
P = 0.013, 95% CI 0.9999–0.9999), better patient-perceived urgent and non-urgent access to primary care (incidence
rate ratio: 0.9989, P = 0.023; 95% CI 0.9979–0.9998 and incidence rate ratio: 0.9988; P = 0.003, 95% CI 0.9980–
0.9996, respectively) and better HbA1c target achievement (incidence rate ratio: 0.9971; P < 0.001, 95% CI 0.9958–
0.9984), were protective. Diabetes admissions decreased significantly during the period 2004–2009.
Conclusions After controlling for population factors, better scheduled primary care access and glycaemic control were
associated with lower hospital admission rates across most complications. There is little rationale to restrict primary
care-sensitive condition definitions to acute complications. They should be revised to improve the usefulness of hospital
admission data as an outcome measure, and to facilitate international comparisons. The risk of emergency hospital
admission should be monitored routinely.
Diabet. Med. 31; 657–665 (2014)
Introduction
Worldwide diabetes prevalence is expected to increase from
2.8% in 2000 to 4.4% in 2030 [1]. In England, there were an
estimated 3.1 million people (7.4%) aged ≥16 years with
diabetes in 2010, and the number is projected to rise to
4.6 million (9.5%) by 2030 [2].
Diabetes complications are common and result in poorer
quality of life and reduced survival. The incidence of
long-term microvascular complications of diabetes has
declined in recent decades [3], but trends in macrovascular
complications of diabetes are less positive. In developed
countries, there has been a decline in mortality from
cardiovascular disease in the general population over three
decades. Although some studies show similar or greater
declines in adults with diabetes [4,5], cardiovascular disease
mortality rates remain much higher. There have been
relatively few recent studies that have included other
endpoints, but in England between 2004 and 2008, the
number of lower limb amputations among people with
diabetes increased, whereas it decreased in the population
without diabetes [6]. There is also evidence that severe
hypoglycaemia in people with diabetes is associated with
adverse outcomes [7]. In addition, acute complications of
diabetes result in a large number of emergency hospital
admissions [8].Correspondence to: Michael Soljak. E-mail: m.soljak@imperial.ac.uk
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Reducing complications and emergency hospital admis-
sions for diabetes are therefore priorities in many coun-
tries. Associations between poor glycaemic control and
adverse outcomes have been well documented [9]. Primary
care-sensitive conditions, or, in the USA, ambulatory
care-sensitive conditions, are diseases for which it is
hypothesized that the risk of emergency hospital admission
can be reduced by high quality primary care, including risk
factor control. Diabetes is included in the primary
care-sensitive condition list used by the National Health
Service (NHS) Outcomes Framework [10], the Prevention
Quality Indicators list of the US Agency for Healthcare
Research and Quality [11], and the Organization for
Economic Co-operation and Development Healthcare
Quality Indicators [12].
In England, emergency hospital admissions for diabetes are
generally to NHS-funded hospitals, and nearly all the popu-
lation is registered with general practices. We investigated, at
general practice level, the associations between hospital
admission rates in four diabetes diagnostic categories (acute
complications, chronic complications, no complications and
hypoglycaemia), and primary healthcare resourcing (access,
practice size and general practitioner supply) and hospital
admission rates in four diabetes diagnostic categories (acute
complications, chronic complications, no complications and
hypoglycaemia), the Quality and Outcomes Framework
(QOF); the general practice pay-for- performance pro-
gramme), diabetes quality indicators and population factors
(deprivation and ethnicity).
Methods
The present study did not require ethics approval as it
was a secondary analysis of routinely available national
data.
Data sources
Hospital Episode Statistics data
All NHS-funded hospitals in England provide hospital admis-
sion data to the Hospital Episode Statistics database, with
diagnoses coded using theWHO’s International Classification
of Diseases 10th revision [ICD-10 (Table 1)]. In ICD-10,
diabetes type is represented by the second and third digits, and
there is no classification of diabetes control. We used primary
care-sensitive condition definitions as a basis for the choice of
complication groups that we included, except for hypoglyca-
emia, another diagnosis group which could be added to these
definitions. We included in our analysis both Type 1 and Type
2 diabetes and all age groups. We used diabetes complications
as a principal diagnosis only, in accordance with all primary
care-sensitive condition definitions, rather than the overall
burden of diabetes complications (Table 1). Many codes for
chronic diabetes complications, in particular, may appear in
subsequent diagnosis fields, with a code for the organ system
affected as the primary diagnosis, but they are not hospital
admissions for diabetes per se. Case-mix funding of NHS
emergency admissions, implemented in 2006–2007, provided
a financial incentive to hospitals to increase the coding of
diabetes complications as secondary diagnoses, as they may
receive additional payment for them. Hospital admissions
with a major complication of diabetes, such as myocardial
infarction or amputation, are likely to be coded with the
complication rather than diabetes as the principal diagnosis.
Hypoglycaemia is currently not part of primary care-sensitive
condition definitions, butwe think it should be, as it is an acute
complication of diabetes treatment, so we included it in the
present analysis.
We calculated the indirectly age-/sex-standardized hospital
admission rates for each practice using practice codes in the
Hospital Episode Statistics data and practice population data
provided by the NHS Information Centre. We did not
distinguish between initial admissions or re-admissions as
primary care-sensitive condition definitions do not make this
distinction.
Quality and Outcomes Framework data
The Quality and Outcomes Framework (QOF), the pay for
performance programme for general practices, QOF uses
data from practice information systems to reward a range of
process and outcome indicators of chronic disease care. We
used practice-level QOF data for the years 2004–2005 to
2009–2010 including data on GP-registered prevalence, as
this may affect admission rates [13]. The diabetes clinical
quality domain includes eight indicators, of which the five
‘intermediate outcome’ indicators used were: Diabetes 6: the
percentage of people with diabetes whose last HbA1c
measurement was ≤57 mmol/mol (7.4%); Diabetes 20: the
percentage of people with diabetes whose last HbA1c
measurement was ≤59 mmol/mol (7.5%); Diabetes 23: the
What’s new?
• Measures of the incidence of diabetes complications are
needed to improve the quality of diabetes care, and
emergency hospital admission data are being used for
this purpose by national health agencies.
• Modifiable risk and healthcare factors associated with
these complications indicate how they may be reduced.
• In the population in England, better scheduled access to
primary healthcare and better glycaemic control were
associated with lower emergency hospital admission
rates for diabetes among patients with acute and
chronic complications, admissions without complica-
tions, and hypoglycaemia.
• A global measure of adverse diabetes outcomes result-
ing in hospital admission should be developed.
658
ª 2014 The Authors.
Diabetic Medicine ª 2014 Diabetes UK
DIABETICMedicine Quality of primary healthcare and admissions for diabetes complications  A. Calderon-Larra~naga et al.
percentage of people with diabetes whose last HbA1c
measurement was ≤53 mmol/mol (7.0%); Diabetes 12: the
percentage of people with diabetes whose last measured
blood pressure was ≤145/85 mm Hg; and Diabetes 17: the
percentage of people with diabetes whose last measured total
cholesterol was ≤ 5 mmol/L.
We defined the HbA1c variable as at or below target
threshold. Because the definition of the QOF indicator target
for glycaemic control has changed very slightly over time
from ≤7.5% to 7.0% and back to ≤ 7.5%, we assumed
identity between the HbA1c indicators Diabetes 6 (the first
HbA1c target), Diabetes 20 and Diabetes 23 (the current
target) to obtain a complete time series. As QOF data are
aggregate we were unable to harmonize these thresholds.
To measure broad access to care from patients’ perspec-
tive, we used two indicators from the QOF Patient Experi-
ence domain: Patient Experience 07, patient experience of
access (1): percentage of people who, in the national survey,
indicated that they were able to obtain a consultation with
their general practitioner within 2 working days and Patient
Experience 08, patient experience of access (2): percentage of
people who, in the national survey, indicated that they were
able to book an appointment with their general practitioner
> 2 days ahead.
Practice size and resourcing
The NHS Information Centre provided data on general
practitioners per 100 000 registered patients, for the years
2004–2005 to 2009–2010, and an annual age/sex breakdown
of practice populations, which was used to indirectly
standardize hospital admission rates (expected counts). Prac-
tices with a list size of < 500 people (99/8300) were excluded
as they were likely to serve atypical populations.
Population data
We used a time series of English Index of Multiple Depri-
vation weightings for each general practice for 2004, 2007
and 2010, produced by aggregating the postcodes of
individual registered people [14]. Diabetes prevalence in a
practice is likely to affect admission rates, so QOF prevalence
was included as a covariate. As ethnicity is an independent
risk factor for adverse outcomes in ethnic minority popula-
tions (controlling for prevalence) [15], we produced esti-
mates of the proportion of South-Asian and black ethnic
minority populations for each practice from ethnicity break-
downs of Hospital Episode Statistics data. This method has
been externally validated [16].
Statistical analysis
We used negative binomial distribution regression rather
than Poisson because there was over-dispersion of the data.
From this, we obtained incidence rate ratios, which in this
context are hospital admission rate ratios. Because of lack of
independence of the data, we adjusted for the clustering
effect of general practice. We assessed correlation coeffi-
cients, fitted bivariate and then multivariate models, and
selected covariates using reverse stepwise selection. Because
we used robust standard errors, which are forced by the use
of cluster options, we have shown Wald-test results to
evaluate model goodness-of-fit. STATA 11 was used for
analysis.
Table 1 International Classification of Diseases 10th revision (ICD-10) diabetes diagnostic categories
ICD-10 three character codes E10 Insulin-dependent diabetes mellitus (Type 1)
E11 Non-insulin-dependent diabetes mellitus (Type 2)
E12 Malnutrition-related diabetes mellitus
E13 Other specified diabetes mellitus
E14 Unspecified diabetes mellitus
E16 Hypoglycaemia*
E87 Acidosis (this category includes lactic acidosis as
an acute problem in diabetes, but also acidosis not
otherwise specified, metabolic acidosis and respiratory
acidosis, so is not useful for diabetes
hospital admissions)
ICD-10 4th character/extension
(The fourth-character subdivisions
are for use with categories E10–E14
only)
Short-term complications* .0 Coma (hyperosmolar/hypoglycaemic/hyperglycaemic)
.1 Ketoacidosis
Long-term complications* .2 + Renal complications (diabetic nephropathy, intracapillary
glomerulonephrosis, Kimmelstiel–Wilson syndrome)
.3 + Ophthalmic complications (cataract, retinopathy)
.4 + Neurological complications (amyotrophy, mononeuropathy,
autonomic neuropathy, polyneuropathy)
.5 Peripheral circulatory complications (gangrene, ulcer,
peripheral angiopathy)
.6 Other specified complications (arthropathy, neuropathic)
.7 Multiple complications
.8 Unspecified complications
No complications* .9 No complications
*Categories of complications we used.
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Results
Characteristics of practice populations and percentage
achievement of QOF indicators are shown in Table 2. After
removing small (<500 registered population) practices, the
study covered 54 741 278 people registered with 8140 (94%
of 8622) general practices. For the QOF indicators chosen,
scores were generally not as high as for some other care
process indicators; for example, in 2009–2010 the mean
practice score for QOF Diabetes indicators 6, 20 and 23, was
only 53.82%, having fallen by almost six percentage points
over 5 years. By contrast, the mean achievement of blood
pressure and lipid control increased by ~10% over the study
period. The mean prevalence of registered diabetes in
England increased from 3.34% in 2004–2005 to 5.46% in
2009–2010, although some of this increase is attributable to
the numerator and denominator changing from all people
with diabetes and the whole population to only those aged >
17 years in both cases in 2007–2008, because prevalence
increases with age. Over the study period, the mean total
diabetes complication hospital admission rates (covering all
four categories) fell from 73.30 to 68.51 per 100 000.
Regression modelling
Table 3 shows the results of the negative binomial multivar-
iable regression analysis for hospital admissions for all the
complication groups. The covariates for general practioner
supply and achievement of total cholesterol targets were
dropped from the model so those results are not shown. The
effect sizes, as measured by incidence rate ratios, were
generally small, apart from year and diabetes prevalence.
Because of this, we have reported results to four decimal
places.
Increasing deprivation score, diabetes prevalence and
achievement of target blood pressure are risk factors for
hospital admission, while most healthcare covariates are
protective; larger practice population, better access to care
Table 2 Admission rates and aggregate characteristics of each practice population in 2004 and 2009
2004 2009
% change P*Mean Interquartile range Mean Interquartile range
Observed hospital admissions/100 000 population
Total hospital admissions with diabetes 73.30 33.69–99.72 68.51 11.45–101.39 6.51% <0.001
Acute complications 20.76 0.00–30.87 19.85 0–29.42 4.38% <0.001
Chronic complications 12.77 0.00–19.58 10.12 0–15.02 20.75% <0.001
No complications 25.20 0.00–38.25 21.87 0–34.48 13.21% <0.001
Hypoglycaemia 14.57 0.00–23.07 16.66 0–26.53 14.34% 0.0018
Age-/sex-standardized hospital admissions/100 000 population*
Total hospital admissions 74.39 33.79–100.69 69.45 11.69–102.88 6.64% <0.001
Acute complications 20.80 0–31.09 19.83 0–29.52 4.66% <0.001
Chronic complications 13.32 0–19.90 10.54 0–14.95 20.87% <0.001
No complications 25.43 0–38.18 22.04 0–34.87 13.33% <0.001
Hypoglycaemia 14.95 0–23.07 17.51 0–27.22 17.12% <0.001
Covariates
Deprivation† 23.43 13.18-31–79 23.77 13.66–32.05 1.45% 0.019
Asian population (%) 6.12 0.33–4.94 7.97 0.53–6.95 30.23% <0.001
Black population 4.00 0.21–3.48 4.67 0.28–4.70 16.75% <0.001
Diabetes prevalence (%) 3.43 2.83–3.91 5.60 4.66–6.35 63.27% <0.001
General practitioner supply/100 000 population 52.78 43.82–59.67 56.47 45.39–64.96 6.99% <0.001
Practice list size 6308.39 3191–8613 6724.97 3437.50–9192.50 6.60% <0.001
QOF Patient Experience indicator 07 (%) 84.32 79.5–93.02 82.07 76.27–91.15 2.67% <0.001
QOF Patient Experience indicator 08 (%) 77.15 67.47–90.52 74.77 64.89–87.60 3.08% <0.001
QOF Diabetes indicator 12 (%) 70.17 63.50–78.13 80.89 76.19–86.27 15.28% <0.001
QOF Diabetes indicator 17 (%) 71.37 64.85–79.31 82.80 79.20–86.91 16.02% <0.001
QOF Diabetes indicators 6, 20 and 23 (%) 58.73 51.70–65.91 53.82 48.48–59.32 8.36% <0.001
*Mann–Whitney test for differences between means.
†Hospital admission rates are adjusted for age and sex (indirectly standardized), calculated as [standardized hospital admission ratio
(observed hospital admission rate indicators counts/expected hospital admission counts)] x [national hospital admission rate/100,000].
Indirect standardization was used because admission numbers are small at general practice level.
‡Weighting for each practice was produced by aggregating Index ofMultiple Deprivation scores from postcodes of individual registered patient.
QOF Patient Experience indicator 07, percentage of people who, in the national survey, indicated that they were able to obtain a consultation
with their general practitioner within 2 working days.
QOF Patient Experience indicator 08, percentage of people who, in the national survey, indicated that they were able to book an
appointment with their general practitioner > 2 days ahead.
QOF Diabetes indicator 12, percentage of people with diabetes whose last blood pressure measurement was ≤145/85 mmHg.
QOF Diabetes indicator 17, percentage of people with diabetes whose last measured total cholesterol within the previous 15 months was
≤5 mmol/l.
QOF Diabetes indicators 6, 20 and 23, percentage of people with diabetes whose last HbA1c measurement was ≤53 mmol/mol (7.0%; or
equivalent test/reference range depending on local laboratory) in the previous 15 months.
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measures and better HbA1c target achievement showed
significant associations with lower hospital admission rates.
Higher proportions of South-Asian and black population are
protective. There is a change over time, with the incidence
rate ratio compared with 2004–2005 falling steadily over
time since the QOF programme commenced.
Table 4 shows the multivariable practice-level analysis for
complication categories. Results are generally consistent with
those for total hospital admissions for some variables; for
example, deprivation and diabetes prevalence remain risk
factors for hospital admission across all categories. Higher
percentage achievement of the HbA1c target and the ability to
book an appointment are protective in most models. In
contrast, higher percentage achievement of the blood pressure
target is a risk factor for hospital admission in all models.
There is no evidence that achievement of total cholesterol
≤5 mmol/l is associated with hospital admission rates.
Discussion
Main findings
In the present observational study of factors associated with
hospital admissions for diabetes complications as a primary
diagnosis, the population factors practice deprivation and
registered diabetes prevalence were associated with higher
diabetes admission rates for all categories of diabetes
complications. Hospital admissions reduced with time over-
all, but only for 2009–2010 compared with 2004–2005 for
most diagnostic categories. The effect sizes were in most
cases small. For example, increasing Diabetes 6, 20 and 23,
the percentage of people with diabetes whose last HbA1c
measurement was ≤53 mmol/mol (7.0%), by 1% would
reduce the admission rate by only 0.29%.
Strengths and limitations
A strength of the present study was its 5-year period of
follow-up after QOF implementation, and the fact that we
were able to analyse categories of diabetes complications.
Annual admission counts per practice were relatively low,
giving low median rates for acute, chronic and hypoglyca-
emia hospital admission categories. We used appropriate
statistical methods to deal with this.
A limitation of the present analysis is that it would have
been desirable to undertake it at an individual patient as
well as at a practice level. Demonstrating an association
between diabetes control and admission rates at the practice
level does not necessarily mean that the same association
exists at patient level. Because the QOF is primarily a
payment system, it is practice- not patient-based, and while
the UK has several large patient-level general practice
research databases, individual practices are not identified in
them. This prevents linkage of patient data with healthcare
quality variables such as QOF indicator achievement and
practice resourcing. Accuracy of diagnostic coding of
diabetes is an important limitation, but to be consistent
with primary care-sensitive condition definitions we only
considered principal diagnoses, and 87.2% of these are
coded correctly [17]. Finally, practice nurses provide a
significant amount of diabetes care, but data on practice
staffing is not available at national level.
Total cholesterol was used instead of LDL cholesterol,
which is a primary lipid target in diabetes care, because the
latter is not available through the QOF. Because these
physiological or intermediate outcome indicators are harder
to achieve than care processes because they involve patient
factors, there is less of a ‘ceiling effect’ (clustering of practice
Table 3 Stepwise multivariable negative binomial regression analysis
for total hospital admissions with diabetes as the primary diagnosis
Incidence
rate ratio* P 95% CI
Deprivation 1.0154 <0.001 1.0141–1.0166
South-Asian
population
0.9919 <0.001 0.9902–0.9935
Black population 0.9937 <0.001 0.9918–0.9955
Diabetes prevalence 1.0956 <0.001 1.0677–1.1241
General practitioner
supply
n/a n/a n/a
Practice list size 0.9999 0.013 0.9999–0.9999
QOF Patient
Experience
indicator 07
0.9989 0.023 0.9979–0.9998
QOF Patient
Experience
indicator 08
0.9988 0.003 0.9980–0.9996
QOF Diabetes
indicator 12
1.0031 <0.001 1.0017–1.0046
QOF Diabetes
indicator 17
0.9987 0.092 0.9971–1.0002
QOF Diabetes
indicators 6/20/23
0.9971 <0.001 0.9958–0.9984
2005 (vs 2004) 0.9970 0.797 0.9741–1.0204
2006 (vs 2004) 0.9102 <0.001 0.8735–0.9484
2007 (vs 2004) 0.9313 0.003 0.8879–0.9768
2008 (vs 2004) 0.9061 <0.001 0.8585–0.9563
2009 (vs 2004) 0.8393 <0.001 0.7856–0.8966
Probability > chi-square < 0.0001.
n/a = dropped from model after stepwise variable selection
process.
QOF Patient Experience indicator 07, percentage of people
who, in the national survey, indicated that they were able to
obtain a consultation with their general practitioner within 2
working days
QOF Patient Experience indicator 08, percentage of people who,
in the national survey, indicated that they were able to book an
appointment with their general practitioner > 2 days ahead
QOF Diabetes indicator 12, percentage of people with diabetes
whose last blood pressure measurement was ≤145/85 mmHg.
QOF Diabetes indicator 17, percentage of people with diabetes
whose last measured total cholesterol within the previous
15 months was ≤ 5 mmol/l.
QOF Diabetes indicators 6/20/23, percentage of people with
diabetes whose last HbA1c measurement was ≤ 53 mmol/mol
(7.0%; or equivalent test/reference range, depending on local
laboratory) in the previous 15 months.
*IRR is incidence rate ratio.
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achievement values around a high achievement percentage)
than with clinical process indicators.
We included the proportion of the practice population
which was black and South Asian in addition to prevalence
because healthcare inequalities in these ethnic groups have
been documented previously. Both these covariates are
protective in most hospital admission categories. These
findings are consistent with evidence that diabetes care in
South-Asian people has improved in recent years, and that
care processes are now similar to those in the rest of the
population, although outcomes may still be poorer [15,18].
Among black people this finding may also be attributable to
increased registration of less severe undiagnosed cases in
recent years, in a population that previously did not access
preventive healthcare as effectively.
The present study examined primary diagnoses only.
While this is a very important element of diabetes compli-
cations and is the focus of international and national primary
care-sensitive condition indicators, developing an overall
diabetes complications categorization that also included
primary diagnoses to which diabetes was a major contributor
would be a more useful global outcome measure. This would
also overcome the limitation of a possible coding shift over
time from diabetes as a primary diagnosis to a secondary
diagnosis. Current primary care-sensitive condition defini-
tions do not take sufficient account of the influence that
primary care could plausibly have.
Comparison with other studies
We found that people’s perception of ability to book
a non-urgent appointment with their general practitioner >
2 days ahead, which is important for ongoing chronic disease
management, was associated with a reduced hospital admis-
sion risk. In contrast, a US study found only a modest effect
of long wait times on primary care utilization, and no robust
effect on health outcomes, including hospital admission [19];
however, they did not control for other aspects of care
quality, and we have documented similar associations for
other diseases [20]. The present analysis suggests that patient
perceptions of access may be clinically important, as they
may influence people to seek emergency care through
Emergency Departments rather than from their general
practice. A larger practice list size may be a marker for
better organization of care and availability of staff.
We found that the percentage of people whose last HbA1c
measurement was ≤ 53 mmol/mol (7.0%) was protective for
all diagnostic categories except hypoglycaemia, but achieve-
ment of this goal deteriorated from 58 to 53% between 2004
and 2009. The HbA1c threshold was lowered in 2009–2010,
which will have lowered achievement slightly. Hyperglyca-
emia generally increases over time, but the QOF has no
patient-level longitudinal data or data on years since diag-
nosis. Another report found some associations at practice
level between admission rates for ‘short-term complications’
and three QOF indicators of glycaemic control [21]. This
analysis covered 2001–2002 to 2006–2007 (2004–2005 was
the first year of the QOF), while we analysed time trends to
2009–2010 to better measure its effects.
The influential Action to Control Cardiovascular Risk in
Diabetes (ACCORD) study, published in 2008, showed that
the use of intensive therapy to target normal HbA1c levels for
3.5 years increased mortality and did not significantly reduce
major cardiovascular disease events [22], and that symptom-
atic, severe hypoglycaemia was associated with an increased
risk of death [23]. These findings may have led to less
subsequent clinical effort to reduce HbA1c to near-normal
levels. A new meta-analysis is consistent with earlier evidence
that the cardiovascular disease benefit of intensive glucose
lowering seems to be modest, and that glucose lowering is
probably less efficacious and more difficult to achieve than
lipid and blood pressure control [24].
Another meta-analysis showed that statins are effective at
decreasing adverse outcomes [25], so a combined approach
that targets glucose lowering, lipid lowering, and blood
pressure control has been proposed [26]. We found no
evidence that a high percentage of patients with total
cholesterol ≤5 mmol/l was associated with admission rates;
however, cholesterol control is more likely to be associated
with admissions for cardiovascular disease complications
rather than for diabetes. Although most people with diabetes
are treated with statins, diabetes is not a disease associated
with high total cholesterol, so many people have values
< 5 mmol/l without specific intervention.
A higher percentage of people with diabetes whose last
blood pressure was ≤145/85 mmHg is a risk factor for
hospital admission in all categories. Recent studies have found
that that targeting near-normal levels of blood pressure has
limited benefit, with most benefit being achieved by targeting
a level of <140 mmHg [27]. A meta-analysis showed that,
with more aggressive goals (<130 mm Hg), the risk of stroke
continued to fall, but there was no reduction in risk of other
events, and the risk of other serious adverse events increased
[28]. A lower blood pressure in older people with diabetes
may also be associated with increasing cardiovascular disease
morbidity and mortality risk [29]. Finally, like cholesterol,
blood pressure control may mainly affect other reasons for
emergency hospital admission such as stroke.
Time since 2004–2005 was generally strongly associated
with lower admission rates, especially in the overall analysis.
As our time series does not extend before QOF started, we
cannot be sure that this effect was because of QOF or other
unmeasured covariates. A previous analysis over the period
2000–2007 reported that QOF had no discernible effects on
hypertension-related processes of care or clinical outcomes,
which improved over time [30]. Registered diabetes preva-
lence increased during the observation period. This may have
resulted in many uncomplicated new cases being identified.
Once on registers, these people will have diluted complica-
tion rates.
ª 2014 The Authors.
Diabetic Medicine ª 2014 Diabetes UK 663
Research article DIABETICMedicine
Conclusions
Most effect sizes for clinical indicators were not large, but
might be greater in countries where primary healthcare
is less well developed. Conversely, our analysis suggests
that the potential for significant reductions in diabetes
emergency hospital admissions by further improving the
clinical quality of primary care may be limited in countries
where it is well-developed. Other initiatives such as patient
education or integrated care may have a greater impact.
For example, the incidence rate ratio for the proportion
of people whose HbA1c is at target is 0.9971, i.e. an
increase of 1% of those reaching this target is associated
with a 0.29% decrease in hospital admissions for
diabetes. In 2009, there were 410 940 hospital admis-
sions with a primary diagnosis of diabetes. A 0.29%
decrease represents only 1192 hospital admissions across
England.
We found primary care factors had an effect on all four
of our categories of complications, suggesting that there
is little rationale in restricting primary care-sensitive condi-
tion definitions to acute complications. Only the US Agency
for Healthcare Research and Quality indicators include a
chronic complications category [11]. Primary care-sen-
sitive condition definitions for diabetes should be reviewed
to take account of our findings, and should include
admissions for hypoglycaemia and ‘no complications’ cat-
egories, as they are as numerous as acute complications
admissions.
In conclusion, there are many difficulties involved in using
routine data sources to monitor diabetes epidemiology and
outcomes, but as they are being widely used for these
purposes, improved coding, accurate and harmonized defi-
nitions, and careful analysis are essential. From a practical,
clinical perspective, it is important firstly to monitor emer-
gency hospital admission rates as an outcome indicator of
ongoing clinical care, and secondly to use the broader
categories we have described here, rather than just acute
complications of Type 1 and Type 2 diabetes.
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